| 生物活性 | |||
|---|---|---|---|
| 靶点 | 
 | ||
| 描述 | Flunixin Meglumine (FM) is a potent inhibitor of COX used as analgesic agent with anti-inflammatory and antipyretic activity. Intravenous FM, 1.1 mg kg-1, significantly inhibited carrageenan-induced exudate PGE2 formation (Emax, 100%, IC50, < 0.4 nM) and serum TXB2 generation (Emax, 100%, IC50, 17 nM) for up to 32 h. Flunixin meglumine significantly inhibited the rise in skin temperature but had a limited effect on exudate WBC(white blood cell). Flunixin meglumine was a more potent COX inhibitor than PBZ (phenylbutazone) and was more selective for the inducible form of COX in vivo[3]. Administration of flunixin meglumine improved pregnancy rates in excitable recipient cows following embryo transfer without affecting the proportion of non-pregnant cows returning to estrus[4]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
| 1 mM 5 mM 10 mM | 2.03mL 0.41mL 0.20mL | 10.17mL 2.03mL 1.02mL | 20.35mL 4.07mL 2.03mL | 
| 参考文献 | 
|---|